Summary & Overview
CPT 55869: Laparoscopic Retropubic Radical Prostatectomy with Bilateral Pelvic Lymphadenectomy
CPT code 55869 represents a laparoscopic retropubic radical prostatectomy performed with nerve-sparing technique and a complete bilateral pelvic lymphadenectomy. Nationally, this code is central to surgical management of clinically localized prostate cancer when minimally invasive and nerve-preserving approaches are used and when pelvic nodal evaluation is performed. Accurate coding affects hospital and surgeon billing, surgical quality measurement, and aggregated utilization analyses for urologic oncology services.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and the implications for payer coverage and claims processing. The publication reviews benchmarks and utilization patterns, notes relevant policy updates that influence prior authorization and coverage of minimally invasive prostatectomy with lymphadenectomy, and summarizes coding considerations that affect reimbursement and quality reporting.
Intended readers will learn how CPT code 55869 is used in documentation and billing, the procedural elements that justify use of this code, and the payer perspectives that commonly shape authorization and payment decisions at a national level. Data not available in the input will be identified as such where applicable.
Billing Code Overview
CPT code 55869 describes a laparoscopic retropubic radical prostatectomy with nerve-sparing technique combined with a complete bilateral pelvic lymphadenectomy. The procedure involves removal of the prostate gland using minimally invasive laparoscopic approaches, may include robotic assistance, and incorporates techniques intended to preserve neurovascular bundles to reduce postoperative sexual and urinary dysfunction.
Service type: Surgical — Minimally invasive urologic oncology procedure with bilateral pelvic lymph node dissection
Typical site of service: Hospital inpatient or ambulatory surgery center
Clinical & Coding Specifications
Clinical Context
A 64-year-old male with intermediate- to high-risk clinically localized prostate adenocarcinoma presents for definitive surgical management. He has rising prostate-specific antigen levels and a diagnostic prostate biopsy confirming adenocarcinoma. Preoperative staging with pelvic MRI and CT or bone scan shows disease confined to the prostate with no distant metastases. The patient elects for definitive surgical treatment and is scheduled for a 55869 laparoscopic retropubic radical prostatectomy with attempted bilateral nerve-sparing and complete bilateral pelvic lymphadenectomy (external iliac, hypogastric/ internal iliac, and obturator nodal groups).
Perioperative workflow includes preoperative counseling, informed consent covering potential urinary incontinence and sexual dysfunction, anesthesia evaluation, antibiotic prophylaxis, venous thromboembolism prophylaxis, and preoperative localization imaging. Intraoperatively, the urologic surgeon performs a minimally invasive retropubic approach—often robot-assisted—dissects and removes the prostate gland with bilateral nerve-sparing when oncologically appropriate, and completes a systematic bilateral pelvic lymph node dissection. Specimens are sent for pathologic analysis (prostate and bilateral lymph nodes). Postoperative care includes pain control, catheter management, mobilization, and discharge planning with outpatient follow-up for pathology review and consideration of adjuvant therapy if indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |